Afarak Group Plc
25.2.2021 15:34:52 CET | Globenewswire | Press release
14:30 London, 16:30Helsinki, 25 February 2021 - Afarak Group Plc ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR)
AFARAK GROUP PLC HAS FILED AN APPLICATION FOR A PERMISSION TO APPEAL AND AN APPEAL TO THE SUPREME ADMINISTRATIVE COURT ON THE HELSINKI ADMINISTRATIVE COURT DECISION
Stock Exchange Release
On 26 January 2021 Afarak released information that Helsinki Administrative Court did not amend the penalty payment of EUR 1 450 000 imposed by FIN-FSA to Afarak for failures relating to disclosure of inside information and maintenance of insider lists.
Afarak has today filed an application for a permission to appeal and an appeal to the Supreme Administrative Court on the decision of the Helsinki Administrative Court.
The Company will update the market in due course about the next steps in the process.
Helsinki, February 25, 2021
AFARAK GROUP PLC
Board of Directors
For additional information, please contact:
Afarak Group Plc
Guy Konsbruck, CEO, +356 2122 1566, guy.konsbruck@afarak.com
Financial reports and other investor information are available on the Company's website: www.afarak.com.
Afarak Group is a specialist alloy producer focused on delivering sustainable growth with a Speciality Alloys business in southern Europe and a FerroAlloys business in South Africa. The Company is listed on NASDAQ Helsinki (AFAGR) and the Main Market of the London Stock Exchange (AFRK).
Distribution:
NASDAQ Helsinki
London Stock Exchange
Main media
www.afarak.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd23.9.2026 22:45:00 CEST | Press release
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET
Teva Pharmaceutical Industries Ltd23.9.2026 22:45:00 CEST | Press release
Teva Releases Q3 2026 Aide Memoire
Zymeworks Inc.23.9.2026 22:01:00 CEST | Press release
Zymeworks Completes Acquisition of Theravance Biopharma
Hebrew University of Jerusalem23.9.2026 20:05:00 CEST | Press release
Your Body Regulates Blood Sugar Better Near Someone You Love New Study Finds
EPH European Property Holdings PLC23.9.2026 19:00:00 CEST | Press release
EPH European Property Holdings PLC announces unaudited interim results for the six months ended 30 June 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
